25 January 2018
Upon production of the first batch of CannEpil at the facility, the batch will undergo validation of manufacturing, analysis and, upon it meeting the required protocols, the Company expects its production facility will be granted full GMP certification.
This full GMP licence will enable MXC to commence full scale manufacture and be licensed for distribution of CannEpil as well as other pharmaceutical grade medicinal cannabis products.
cannepil question and other questions, page-17
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
-0.035(9.72%) |
Mkt cap ! $15.73M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.0¢ | 32.0¢ | $12.54K | 38.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1666 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 100 | 1 |
View Market Depth
| Last trade - 15.52pm 10/09/2024 (20 minute delay) ? |
| RGT (ASX) Chart |